about
A review of therapies for diabetic macular oedema and rationale for combination therapyPseudophakic cystoid macular edema: update 2016Protocol: Effect of intravitreal bevacizumab (avastin) in the treatment of macular edema: A systematic review of randomized controlled trialsUpcoming therapeutic advances in diabetic macular edema: an intravitreal dexamethasone drug delivery system.Macular abnormalities in Italian patients with retinitis pigmentosa.Cystoid macular edema after cataract surgery in a patient with previous severe iritis following argon laser peripheral iridoplasty.Etiology and treatment of the inflammatory causes of cystoid macular edema.Novel atypical PKC inhibitors prevent vascular endothelial growth factor-induced blood-retinal barrier dysfunctionShould steroids be offered to patients with nonarteritic anterior ischemic optic neuropathy?Detection of cystoid macular edema with three-dimensional optical coherence tomography versus fluorescein angiographyAnti-vascular endothelial growth factor therapy for diabetic macular edemaImportance of Central Retinal Sensitivity for Prediction of Visual Acuity after Intravitreal Bevacizumb in Eyes with Macular Edema Associated with Branch Retinal Vein Occlusion.Cystoid macular edema in acute presentation of central retinal artery occlusionEvaluation of nepafenac in prevention of macular edema following cataract surgery in patients with diabetic retinopathy.Novel grading system for quantification of cystic macular lesions in Usher syndrome.Transient cystoid macular oedema in multiple choroidal naeviImpact of injection therapy on retinal patients with diabetic macular edema or retinal vein occlusionInflammation in retinal diseaseCombined cataract and glaucoma surgery: the effect of pupil enlargement on surgical outcomes (an American Ophthalmological Society thesis)Comparison of Cysts in Red and Green Images for Diabetic Macular EdemaCosts and Quality of Life in Diabetic Macular Edema: Canadian Burden of Diabetic Macular Edema Observational Study (C-REALITY).Vascular endothelial growth factor modulates the function of the retinal pigment epithelium in vivo.Pharmacokinetics of triamcinolone acetonide for the treatment of macular edema.Predicting visual outcomes for macular disease using optical coherence tomography.Inflammation and macular oedema after pars plana vitrectomy.Complications of intravitreal injections in patients with diabetes.Efficacy and vitreous levels of topical NSAIDs.Ultrasound-mediated ocular delivery of therapeutic agents: a review.Spectral domain optical coherence tomography in the diagnosis and management of vitreoretinal interface pathologies.Imaging chorioretinal vascular disease.The effect of topical sodium diclofenac on macular thickness in diabetic eyes after phacoemulsification: a randomized controlled trial.Effect of Topical Nepafenac on Central Foveal Thickness following Panretinal Photocoagulation in Diabetic Patients.Prophylactic postoperative ketorolac improves outcomes in diabetic patients assigned for cataract surgery.Optical coherence tomography classification of diabetic cystoid macular edemaIntravitreal combination of triamcinolone acetonide and bevacizumab (Kenacort-Avastin) in diffuse diabetic macular edema.Visual acuity and microperimetric mapping of lesion area in eyes with inflammatory cystoid macular oedema.Influence of orthostasis and daytime on retinal thickness in uveitis-associated cystoid macular edema.Fingolimod and macular edema: Pathophysiology, diagnosis, and management.Transient MEK inhibitor-associated retinopathy in metastatic melanoma.Multimodal imaging in paclitaxel-induced macular edema: the microtubule disfunction.
P2860
Q27008325-629BFF53-8172-4E4A-AAE4-240262DE4622Q28076636-2DE83F21-8F18-4AC3-B01F-1F52B227B66EQ28680651-1BEF26DE-2A17-43D0-89B6-AB9F74B1C6FBQ33790255-37E4A739-6173-4DAF-A8AD-B378DBBD28E9Q33834398-159C2DD6-4859-4254-A49A-1E567BA46512Q33900517-E353C309-4698-4F2D-AF6D-AA2016E2AF9BQ34077613-D56AA2DE-0785-42D9-A099-FEAE23F8470DQ34313113-D5E5DC16-097C-4702-8767-8B4B422C0900Q34369926-510D2A32-CBBC-4615-982D-A75B23E69F1FQ34735272-A93AD733-8E4C-4E62-AF1D-C9668372D3CCQ35064343-AE7C1EFC-40D5-484F-A8A6-A8384E967FA6Q35925907-408269E1-04C9-4616-997F-E9848ABFA977Q35952406-9B635788-0685-441C-B440-99F1D1DE1647Q36173245-75D8D62F-0833-4BF1-B751-7B6AA2DD3935Q36364360-0BB1E411-9ABF-44ED-8583-45CC718AD4DFQ36795543-F998D6B2-EB1C-416A-B482-5AD767A5E171Q36955704-1F5274DE-41EB-4DFF-B1EE-32788E6D82F3Q37200268-75FCF029-FEF4-4545-B744-BABDD6F1910AQ37404341-EC1BCB32-D0D0-49DB-8130-28C2EEB734D1Q37607065-1B4A783E-325C-4BCB-A8AA-977F44188183Q37699938-9C974A27-AC87-450D-8C37-A26D3DC8E833Q37700907-E3549C2D-9578-4C17-9988-567B5223A8ACQ37905833-8B5DB7A2-F2C4-4833-84F7-2330270F6669Q38130239-081418D1-44C4-49F7-96C0-512609C5A914Q38167310-78309319-697C-4254-8AB1-42AAAF82CDAFQ38261106-17F63FAE-F0D1-40B3-AD36-303BA261FE72Q38546915-C8F4195C-F35C-4D10-8510-1716A36D84B6Q38867140-854C9BB9-8B0C-4321-A63E-B3B224926FC5Q39602232-A98E6763-2B33-4FB4-8C8E-88A6F036A823Q39919254-47B58007-75F0-4305-AB44-ABE2D3A3B449Q40854679-56972DAE-5D50-4D19-B999-D45B702766FAQ40979686-6D420D6A-FE80-4E48-9B37-1B7BB48ADC06Q41317828-89026991-34F0-4F72-AFC1-23CA399057DDQ42131351-B39468FD-47F7-4A89-88CD-D8970855AD23Q43232067-BF35E8B0-07FD-4C0F-9206-C49E7DBA9A52Q43767421-B753C4C3-0F8F-4952-8B64-8910E5354CDDQ45822442-9FBBDE68-80AE-4174-8E34-406D3050208BQ49480620-0C3EA9D4-EA5F-4B96-8CBD-CCE973823F67Q50455744-8243E903-17A3-4CB4-948F-BEE8E49E0BB1Q51063322-AA3CF4BC-A6B6-45BA-992C-581383CD455E
P2860
description
2008 nî lūn-bûn
@nan
2008 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
2008 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
2008年の論文
@ja
2008年論文
@yue
2008年論文
@zh-hant
2008年論文
@zh-hk
2008年論文
@zh-mo
2008年論文
@zh-tw
2008年论文
@wuu
name
Etiology and treatment of macular edema.
@ast
Etiology and treatment of macular edema.
@en
type
label
Etiology and treatment of macular edema.
@ast
Etiology and treatment of macular edema.
@en
prefLabel
Etiology and treatment of macular edema.
@ast
Etiology and treatment of macular edema.
@en
P1476
Etiology and treatment of macular edema.
@en
P2093
Mark W Johnson
P304
P356
10.1016/J.AJO.2008.07.024
P407
P577
2008-09-13T00:00:00Z